These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 307429)

  • 1. Role of intracisternal A-particles and of RNA molecules in plasmacytoma-associated immunodeficiency.
    Katzmann J; Bhoopalam N; Heller P; Hwang LT; Ostro M; Lavelle D; Giacomoni D
    Cancer Res; 1978 Aug; 38(8):2555-61. PubMed ID: 307429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface immunoglobulins of lymphocytes in mouse plasmacytoma. IV. Evidence for the persistence of the effect of plasmacytoma-RNA on the surface immunoglobulins of normal lymphocytes in vivo and in vitro.
    Bhoopalam N; Yakulis V; Giacomoni D; Heller P
    Clin Exp Immunol; 1976 Jan; 23(1):139-48. PubMed ID: 57019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression in plasmacytoma: induction of suppressor cells.
    Chen Y; Hwang LT; Heller P
    Clin Exp Immunol; 1982 Jan; 47(1):191-6. PubMed ID: 6212173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface immunoglobulins of lymphocytes in plasmacytoma. V. The effect of RNA-rich extract from mouse plasmacytoma MOPC 104E on the immune response.
    Bhoopalam N; Chen Y; Yakulis V; Heller P
    Clin Exp Immunol; 1976 May; 24(2):357-67. PubMed ID: 1277583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune RNA-mediated transfer of tumor antigen responsiveness to unresponsive peritoneal exudate cells from tumor-bearing animals.
    Braun DP; Dray S
    Cancer Res; 1977 Nov; 37(11):4138-44. PubMed ID: 908048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against MOPC-315 plasmacytoma by immunization with C-type particle preparations.
    Kleinman R; Dray S
    Cancer Res; 1978 Jan; 38(1):223-5. PubMed ID: 201375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of surface immunoglobulin in murine and human myeloma and chronic lymphocytic leukemia.
    Heller P
    Ann Clin Lab Sci; 1978; 8(3):254-7. PubMed ID: 306797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of T, B and adherent cells in the in vitro immune response of TEPC-183-bearing mice.
    Patel M; Havas HF
    Immunology; 1982 May; 46(1):97-105. PubMed ID: 6978846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface immunoglobulins on circulating lymphocytes in mouse and human plasmacytoma.
    Heller P; Yakulis V; Bhoopalam N; Costea N; Cabana V; Nathan RD
    Trans Assoc Am Physicians; 1972; 85():192-202. PubMed ID: 4633774
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune dysfunction in mice with plasmacytomas. I. Evidence that transforming growth factor-beta contributes to the altered expression of activation receptors on host B lymphocytes.
    Berg DJ; Lynch RG
    J Immunol; 1991 Apr; 146(8):2865-72. PubMed ID: 1826699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular changes and antitumor responses in the plasmacytoma-bearing mouse following cyclophosphamide treatment.
    Shanahan TC; Ceglowski WS; Havas HF
    Cancer Res; 1985 Dec; 45(12 Pt 1):6463-70. PubMed ID: 2866030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of an IgM plasmacytoma (TEPC-183) on the primary immune response of BALB/c mice.
    Havas HF; Schiffman G
    Immunology; 1978 Jan; 34(1):1-8. PubMed ID: 23993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type C virus particles in X63-Ag8.653 mouse plasmacytoma cells and in hybridomas derived from it.
    Rudolph M; Karsten U; Micheel B
    Arch Geschwulstforsch; 1983; 53(6):513-9. PubMed ID: 6670912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of two plasmacytoma fractions and their RNA capable of changing lymphocyte surface immunoglobulins (cell conversion).
    Katzmann J; Giacomoni D; Yakulis V; Heller P
    Cell Immunol; 1975 Jul; 18(1):98-109. PubMed ID: 1139638
    [No Abstract]   [Full Text] [Related]  

  • 15. Myeloma-induced immunosuppression: a multistep mechanism.
    Katzmann JA
    J Immunol; 1978 Oct; 121(4):1405-9. PubMed ID: 701801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular specificity of plasmacytoma-induced immunosuppression.
    Zolla-Pazner S; Sullivan B; Richardson D
    J Immunol; 1976 Aug; 117(2):563-8. PubMed ID: 1084903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mode of action of splenic suppressor cells in murine plasmacytoma.
    Chen Y; Heller P
    Clin Exp Immunol; 1981 Sep; 45(3):514-22. PubMed ID: 6461449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple expression of Ig lambda-chain encoding RNA species in murine plasmacytoma cells.
    Schwartz RC; Sonenshein GE; Bothwell A; Gefter ML
    J Immunol; 1981 Jun; 126(6):2104-8. PubMed ID: 6164720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoprecipitation of intracisternal A-particle-associated antigens from preimplantation mouse embryos.
    Huang TT; Calarco PG
    J Natl Cancer Inst; 1981 Nov; 67(5):1129-34. PubMed ID: 6272013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.